A citation-based method for searching scientific literature

Chad J Swanson, Mark Bures, Michael P Johnson, Anni-Maija Linden, James A Monn, Darryle D Schoepp. Nat Rev Drug Discov 2005
Times Cited: 457







List of co-cited articles
757 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metabotropic glutamate receptors: physiology, pharmacology, and disease.
Colleen M Niswender, P Jeffrey Conn. Annu Rev Pharmacol Toxicol 2010
28

Metabotropic glutamate receptors: from the workbench to the bedside.
F Nicoletti, J Bockaert, G L Collingridge, P J Conn, F Ferraguti, D D Schoepp, J T Wroblewski, J P Pin. Neuropharmacology 2011
399
16

Pharmacology and functions of metabotropic glutamate receptors.
P J Conn, J P Pin. Annu Rev Pharmacol Toxicol 1997
12

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
Sandeep T Patil, Lu Zhang, Ferenc Martenyi, Stephen L Lowe, Kimberley A Jackson, Boris V Andreev, Alla S Avedisova, Leonid M Bardenstein, Issak Y Gurovich, Margarita A Morozova,[...]. Nat Med 2007
780
11

The metabotropic glutamate receptors: structure and functions.
J P Pin, R Duvoisin. Neuropharmacology 1995
10


Metabotropic glutamate receptors.
Francesco Ferraguti, Ryuichi Shigemoto. Cell Tissue Res 2006
352
9



The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission.
Maurizio Popoli, Zhen Yan, Bruce S McEwen, Gerard Sanacora. Nat Rev Neurosci 2011
751
8

Development of allosteric modulators of GPCRs for treatment of CNS disorders.
Hilary Highfield Nickols, P Jeffrey Conn. Neurobiol Dis 2014
146
7

Glutamate receptor ion channels: structure, regulation, and function.
Stephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, Frank S Menniti, Katie M Vance, Kevin K Ogden, Kasper B Hansen, Hongjie Yuan, Scott J Myers, Ray Dingledine. Pharmacol Rev 2010
7


Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.
Gerard Sanacora, Carlos A Zarate, John H Krystal, Husseini K Manji. Nat Rev Drug Discov 2008
593
7

Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
E Tatarczyńska, A Klodzińska, E Chojnacka-Wójcik, A Palucha, F Gasparini, R Kuhn, A Pilc. Br J Pharmacol 2001
256
7


Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.
Richard H P Porter, Georg Jaeschke, Will Spooren, Theresa M Ballard, Bernd Büttelmann, Sabine Kolczewski, Jens-Uwe Peters, Eric Prinssen, Jürgen Wichmann, Eric Vieira,[...]. J Pharmacol Exp Ther 2005
229
6


LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress.
Darryle D Schoepp, Rebecca A Wright, Louise R Levine, Brenda Gaydos, William Z Potter. Stress 2003
173
6

Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.
I V Belozertseva, T Kos, P Popik, W Danysz, A Y Bespalov. Eur Neuropsychopharmacol 2007
146
6

Glutamate and anxiety.
Veerle Bergink, Harold J G M van Megen, Herman G M Westenberg. Eur Neuropsychopharmacol 2004
148
6

Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain.
R Shigemoto, S Nomura, H Ohishi, H Sugihara, S Nakanishi, N Mizuno. Neurosci Lett 1993
446
6


Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
P Jeffrey Conn, Arthur Christopoulos, Craig W Lindsley. Nat Rev Drug Discov 2009
746
5

Pharmacological agents acting at subtypes of metabotropic glutamate receptors.
D D Schoepp, D E Jane, J A Monn. Neuropharmacology 1999
876
5

Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice.
Xia Li, Anne B Need, Melvyn Baez, Jeffrey M Witkin. J Pharmacol Exp Ther 2006
131
5

Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
Lothar Lindemann, Richard H Porter, Sebastian H Scharf, Basil Kuennecke, Andreas Bruns, Markus von Kienlin, Anthony C Harrison, Axel Paehler, Christoph Funk, Andreas Gloge,[...]. J Pharmacol Exp Ther 2015
69
7

Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse.
S H Kim, J W Steele, S W Lee, G D Clemenson, T A Carter, K Treuner, R Gadient, P Wedel, C Glabe, C Barlow,[...]. Mol Psychiatry 2014
38
13


Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder.
Eduardo Dunayevich, Janelle Erickson, Louise Levine, Ronald Landbloom, Darryle D Schoepp, Gary D Tollefson. Neuropsychopharmacology 2008
146
5

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.
Shigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota, Toshiharu Shimazaki, Maoko Maeda, Naoya Kawashima, Takao Yoshimizu, Akito Yasuhara, Kazunari Sakagami, Shigeru Okuyama,[...]. Neuropharmacology 2004
190
5

Ionotropic and metabotropic glutamate receptor structure and pharmacology.
James N C Kew, John A Kemp. Psychopharmacology (Berl) 2005
469
5

mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082.
Kenneth A Pelkey, Xiaoqing Yuan, Gabriela Lavezzari, Katherine W Roche, Chris J McBain. Neuropharmacology 2007
96
5

The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders.
Daniel Peterlik, Peter J Flor, Nicole Uschold-Schmidt. Curr Neuropharmacol 2016
26
19

A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo.
Kayo Mitsukawa, Rina Yamamoto, Silvio Ofner, Joachim Nozulak, Oliver Pescott, Snezana Lukic, Natacha Stoehr, Cedric Mombereau, Rainer Kuhn, Kevin H McAllister,[...]. Proc Natl Acad Sci U S A 2005
195
5

Activation of the mGlu7 receptor elicits antidepressant-like effects in mice.
Agnieszka Palucha, Kinga Klak, Piotr Branski, Herman van der Putten, Peter J Flor, Andrzej Pilc. Psychopharmacology (Berl) 2007
118
5


New perspectives in glutamate and anxiety.
Carlos Riaza Bermudo-Soriano, M Mercedes Perez-Rodriguez, Concepcion Vaquero-Lorenzo, Enrique Baca-Garcia. Pharmacol Biochem Behav 2012
126
5

Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain.
C Romano, M A Sesma, C T McDonald, K O'Malley, A N Van den Pol, J W Olney. J Comp Neurol 1995
559
5


Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Jorge A Quiroz, Paul Tamburri, Dennis Deptula, Ludger Banken, Ulrich Beyer, Michael Rabbia, Nikhat Parkar, Paulo Fontoura, Luca Santarelli. JAMA Psychiatry 2016
74
6

Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins.
J C Tu, B Xiao, S Naisbitt, J P Yuan, R S Petralia, P Brakeman, A Doan, V K Aakalu, A A Lanahan, M Sheng,[...]. Neuron 1999
802
5


Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications.
Enza Palazzo, Ida Marabese, Vito de Novellis, Francesco Rossi, Sabatino Maione. Curr Neuropharmacol 2016
26
19

Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.
Luisa Di Menna, Max E Joffe, Luisa Iacovelli, Rosamaria Orlando, Craig W Lindsley, Jèrome Mairesse, Pierre Gressèns, Milena Cannella, Filippo Caraci, Agata Copani,[...]. Neuropharmacology 2018
50
10


The metabotropic glutamate receptors: structure, activation mechanism and pharmacology.
Jean-Philippe Pin, Francine Acher. Curr Drug Targets CNS Neurol Disord 2002
181
4



Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor.
N Kunishima, Y Shimada, Y Tsuji, T Sato, M Yamamoto, T Kumasaka, S Nakanishi, H Jingami, K Morikawa. Nature 2000
925
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.